mghsteelelabs.bsky.social
@mghsteelelabs.bsky.social
Publication alert 🚨 Mutant p53 hijacks enhancers to drive CXCL1 expression and create an immunosuppressive TME in #PDAC. Targeting these enhancer-chemokine circuits could boost immunotherapy in PDAC. t.co/K84OB4NlOx #MGHCancerCenter #kochinstitute @harvardmed.bsky.social
June 30, 2025 at 6:54 PM